Health Logic Interactive Announces the Resignation of CEO and Appoints New Interim CEO to Focus on New Acquisition Targets

About this update from Health Logic Interactive Inc

[{"type":"text","content":"\n \n \n \n Health Logic Interactive Announces the Resignation of CEO and Appoints New Interim CEO to Focus on New Acquisition Targets\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n CALGARY, AB\n \n ,\n \n Nov. 16, 2021\n \n /CNW/ -\n \n Health Logic Interactive Inc\n \n . (\"\n \n Health Logic\n \n \" or the \"\n \n Company\n \n \") (TSXV: CHIP.H) (OTCPK: CHYPF) is pleased to announce the hiring of Mr.\n \n Harrison Ross\n \n as interim Chief Executive Officer for Health Logic and the resignation of Mr.\n \n David Barthel\n \n . In his role Mr. Ross will look to finalize the sale of the Company's wholly owned subsidiary, My Health Logic Inc. (\"\n \n My Health Logic\n \n \"), to Marizyme Inc. (\"\n \n Marizyme\n \n \") and begin the new strategic direction of the Company.\n \n \n \n \n \n \n \n \n \n Mr. Ross, a charted financial accountant (CFA), was previously the Company's CFO and is well versed in the Company history and will be in charge of leading the future direction of the Company. As the previous CFO of Health Logic, he was essential to the initial building of the business, helping restructure the previous shell, financing the Company, and streamlining of the business' operations to help develop MATLOC 1 and the accompanying lab-on-chip technology. The sale of My Health Logic to Marizyme is expected to be complete this\n \n December 2021\n \n .\n \n \n While the expected sale of My Health Logic closes, the Company will be actively looking for other acquisition and financing opportunities to prepare for a successful reactivation to the Tier ll of the TSX Venture Exchange (the \"\n \n TSXV\n \n \") based on continued listing requirements.\n \n \n In addition to Mr. Ross' move from CFO to CEO, all directors of Health Logic will remain directors of the Company,\n \n George Kovalyov\n \n will move from COO to CFO of the Company, and\n \n David Barthel\n \n will resign as CEO of the Company and transition to Marizyme as their new CEO. Health Logic thanks Mr. Barthel for his excellent efforts in leading the Company and bel...

More updates from Health Logic Interactive Inc